[微泡性脂肪变性]
[Microvesicular steatosis].
作者信息
Ionescu D L
机构信息
Facultatea de Medicină Clinica a II-a Medicală Gastroenterologie, Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi.
出版信息
Rev Med Chir Soc Med Nat Iasi. 2002 Apr-Jun;107(2):268-72.
BACKGROUND
"Bright" liver at ultrasonography predicts fatty liver.
AIM
To assess prevalence and predictors of a bright liver.
METHODS
Prevalence arm--Prospective collection of records of unselected patients undergoing liver ultrasound. Protocol arm--A sample of patients with bright liver underwent routine laboratory investigations, liver tests, HBsAg and anti-HCV.
RESULTS
No difference was found in mean values of fasting plasma glucose, LDL cholesterol, total bilirubin, GOT, GPT, AP, GGT, and serum bile acids or in the prevalence of serum HBsAg and anti-HCV in bright liver vs control groups. Univariate analysis showed body mass index, age, total cholesterol triglycerides, albumin, HDL cholesterol to be significantly.
CONCLUSIONS
Roughly 20% of patients undergoing US for routine clinical practice will have a bright liver and levels are the independent predictors of a bright liver.
背景
超声检查时肝脏“回声增强”提示脂肪肝。
目的
评估肝脏回声增强的患病率及预测因素。
方法
患病率研究组——前瞻性收集未选患者肝脏超声检查记录。方案研究组——对肝脏回声增强患者样本进行常规实验室检查、肝功能检查、乙肝表面抗原及丙肝抗体检测。
结果
肝脏回声增强组与对照组在空腹血糖、低密度脂蛋白胆固醇、总胆红素、谷草转氨酶、谷丙转氨酶、碱性磷酸酶、γ-谷氨酰转肽酶及血清胆汁酸平均值或血清乙肝表面抗原及丙肝抗体患病率方面未发现差异。单因素分析显示体重指数、年龄、总胆固醇、甘油三酯、白蛋白、高密度脂蛋白胆固醇有显著意义。
结论
在常规临床实践中接受超声检查的患者中，约20%会出现肝脏回声增强，且这些指标是肝脏回声增强的独立预测因素。
Zotero 插件